Editas Medicine Inc(8EM) News

Date	Title
May 25	1 Stock Down 97% That Could Double, According to Wall Street
Apr 28	Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting